Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

We have observed 8 EP applications Jasber Kaur Bhogal has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after May 21, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12827181

VIRAL CLEARANCE METHODS

IPC classification:
C07K 1/00, C07K 16/00
Agent:
Jasber Kaur Bhogal, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12764025

BUFFER SYSTEM FOR PROTEIN PURIFICATION

IPC classification:
C07K 1/18, C07K 1/22, C07K 1/36
Applicant:
GlaxoSmithKline LLC
Agent:
Jasber Kaur Bhogal, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP12768307

FORMULATIONS WITH REDUCED VISCOSITY

IPC classification:
A61K 39/00, C07K 16/24
Applicant:
GlaxoSmithKline LLC
Agent:
Jasber Kaur Bhogal, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13701484

FERMENTATION PROCESS

IPC classification:
A61K 39/00
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Jasber Kaur Bhogal, GlaxoSmithKline
Status:
The patent has been granted
EP13731327

FERMENTATION PROCESS

IPC classification:
C12M 1/00, C12M 1/12, C12M 1/26, C12P 1/04, C12P 21/00
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Jasber Kaur Bhogal, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP14702533

METHOD OF PRODUCING A PROTEIN

IPC classification:
C07K 1/14
Applicant:
Glaxo Group Limited
Agent:
Jasber Kaur Bhogal, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP14713926

METHODS FOR PURIFYING ANTIBODIES

IPC classification:
B01D 15/20, B01D 15/38, C07K 1/22, C07K 16/00
Applicant:
GlaxoSmithkline Intellectual Property (No. 2) Limited
Agent:
Jasber Kaur Bhogal, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP14715423

USE OF TRICARBOXYLIC ACID (TCA) INTERMEDIATES TO CONTROL AMMONIA GENERATION IN CELL CULTURE

IPC classification:
C12N 5/00, C12P 21/00
Applicant:
GlaxoSmithkline Intellectual Property (No. 2) Limited
Agent:
Jasber Kaur Bhogal, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS

Please Sign in to use this feature